1. Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression
   Lingyu Xue et al, 2017, BMC Nephrology CrossRef
2. Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials
   Juan Jose Garcia Sanchez et al, 2022, Advances in Therapy CrossRef
3. Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
   Chen-Ta Yang et al, 2018, Journal of Clinical Medicine CrossRef
4. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease
   Andrew S. Brem et al, 2015, Clinical Science CrossRef
5. Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease
   Kaiyue Ding et al, 2023, European Journal of Internal Medicine CrossRef
6. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
   Gemma Currie et al, 2016, BMC Nephrology CrossRef
7. Kidney parenchymal hypertension
   Martin J. Andersen et al, 2019, Nephrology Secrets CrossRef
8. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
   null null et al, 2020, Cochrane Database of Systematic Reviews CrossRef
9. Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis
   Lorenzo Villa-Zapata et al, 2021, American Journal of Health-System Pharmacy CrossRef
10. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes
    MIN YAO et al, 2015, International Journal of Molecular Medicine CrossRef
11. Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
    Wiktoria Baran et al, 2021, International Journal of Molecular Sciences CrossRef